April 26, 2012
Change of the Name of Kirin Kunpeng (China) Bio-Pharmaceutical Co., Ltd.
Tokyo, Japan, April 26, 2012 --- "Kirin Kunpeng (China) Bio-Pharmaceutical Co., Ltd.," a subsidiary of Kyowa Hakko Kirin Co., Ltd., ("Kyowa Hakko Kirin") and engaged in developing, manufacturing, and selling ethical drugs in China, changed its name to "Kyowa Hakko Kirin China Pharmaceutical Co., Ltd.," effective April 23, 2012.
<Reason for the change>
Kyowa Hakko Kirin took full ownership of Kirin Kunpeng (China) Bio-Pharmaceutical Co., Ltd., as a fully owned subsidiary in 2010.
Outline of Kyowa Hakko Kirin China Pharmaceutical Co., Ltd.
|Established||June 26, 1997|
|Located||970 Long Dong Road, Z. J. High-Tech Park, Pudong New Area, Shanghai, China 201203|
|General Manager||Toshihiro Onodera|
|Capital||29.8 million U.S. dollars|
|Shareholder||Kyowa Hakko Kirin Co., Ltd. (100%)|
|Sales||230 million CNY (2011)|
|Business Areas||Development, manufacturing, and sale of ethical drugs in China|
|Main Office||Head office, factory: Shanghai
Office: Beijing, Guangzhou, Hangzhou, Chengdu, Hefei